The impact of volume-based procurement policy on the pharmaceutical industry: A systematic review based on the SCP paradigm

Corresponding author: MAO Zong-fu, zfmao@whu.edu.cn

DOI: 10.12201/bmr.202401.00003

•  

  Abstract: Objective: To systematically review the impact of Chinese volume-based procurement (VBP) policy on the pharmaceutical industry. Methods: Relevant literature published between January 1, 2019 and July 31, 2023 were retrieved from the database of CNKI, WanFang data, PubMed, and Web of Science. A thematic analysis framework was constructed for data collation and analysis applying the Structure-Conduct-Performance (SCP) paradigm. Results: Forty-one studies were included, with 10 (24.4%), 24 (58.5%), and 23 (56.1%) reporting the dimension of structure, conduct, and performance, covering 10 secondary themes. Literature shows that, in terms of market structure, the market share of bid-winning enterprises increased after VBP policy, and the concentration ratio of pharmaceutical industry promoted; as for enterprise conduct, the R&D investment of both bid-winning and bid-non-winning enterprises increased under policy implementation, and the selling expenses on policy-covered products significantly reduced while policy-uncovered products did not; as for industry performance, the impact of VBP policy on operational performance varies among enterprise, and the initially positive effect on promoting innovative output of bid-winning enterprises was observed. Conclusion: The VBP policy has shown positive effects in optimizing market structure, guiding enterprise conduct, and improving industry performance. To consolidate and expand policy effects, it is recommended to further strengthen the comprehensive management of drug prices, expand the boundaries of the VBP market, and strengthen policy monitoring and tracking research.

  Key words: volume-based procurement; pharmaceutical industry; systematic review; SCP paradigm

  Submit time: 12 January 2024

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• ZENGXUHENG, ZHENGJI, LVJUN, NINGYULING, LIXIAOHONG. SWOT analysis on volume-based procurement of high-value medical consumables: A case of Shanghai. 2020. doi: 10.12201/bmr.202010.00841

  SUN Wenjun, ZHAO Ziyin, CHENG Zheyu, LI Huining, ZHU He. Impact of the national centralized drug procurement policy on drug prices and utilization: a systematic review. 2023. doi: 10.12201/bmr.202303.00033

  Sun Yan, Zhu Zheng, Yang Li. Influencing factors analysis on price reduction in national volume-based drug procurement.. 2022. doi: 10.12201/bmr.202203.00008

  LIU MINGZHU, LU YUN. Research on the Implementation Effect of Expiration of National Pharmaceutical Centralized Volume-based Procurement Based on Intermittent Time Series: A Case Study of Hebei Province. 2023. doi: 10.12201/bmr.202306.00007

  HAN Meng, WANG Shi-jia, HU Hao-yu, ZHAO Yan-jiao, CHEN Yong-fa. Comparative Study on Grouping Rules in Centralized Volume-based Procurement of Chinese Patent Medicine. 2023. doi: 10.12201/bmr.202312.00008

  WangBiao, Zhang Tiantian, Tang Xiaoyu, Jia Yun, Luo Li. A study of price reduction sustainability in national volume-based drug procurement. 2023. doi: 10.12201/bmr.202305.00008

  songjia, fanchengxin, wangwanchen, aixufeng, liuxinlu, licuiyu, zhangyujie, liqiusha, wanganqi, fengzhiqiang, yinwenqiang, madongping. Study on Chinas centralized quantity purchasing policy for drugs from the perspective of stakeholders - a textual analysis based on policy tools. 2022. doi: 10.12201/bmr.202203.00006

  Tang Yuqing, Li Yinming, Chen Xizhuo, Xue Tianqin, Chen Hao. Analysis of the Execution of Centralized Drug Procurement Policy Based on Policy Implementation System Model. 2023. doi: 10.12201/bmr.202310.00002

  mahanbin, Zhao Jing, Guan Yongyi, Zhang Fengyi, Yang Lijin, Liu Senyuan. Policy Analysis of Chinese Medicine Industrialization Based on Policy Tools. 2023. doi: 10.12201/bmr.202304.00006

  WangBiao, Zhang Tiantian, Tang Xiaoyu, Jia Yun, Luo Li. Research on the price difference and regional distribution of selected drugs in Chinas centralized procurement. 2023. doi: 10.12201/bmr.202306.00008

• ID	Submit time	Number	Download
  1	2023-09-11	bmr.202401.00003V1	Download

• Public  Anonymous  To author only Submit Comments